. 2018 Mar 2;67(5):843–853. doi: 10.1007/s00262-018-2141-0

Table 1.

Characteristics of 25 patients with hepatic malignancies treated by selective internal radiotherapy

Female/male	5/20
Median age (range), years	73 (33–84)
Median administered activity (range), GBq	2.92 (1.01–6.42)
Median of target volume doses (range), Gy	119 (110–282)
Median lung dose^a (range), Gy	6.45 (1–21.4)
Median pulmonary shunt (range) %	4.4 (1.3–28.1)
No. of treatment cycle
1st	21
2nd	3
3rd	1
Primary tumor
Liver	24
CUP	1
Metastases
Without	10
Lungs	4
Adrenal gland	2
Bones	2
Pancreas	1
Stomach	1
Other	5
Without/with bone metastases	23/2
Child–Pugh class^a
No liver cirrhosis = 0	3
A = 1	21
Without/with chronic kidney disease	20/5
Without/with diabetes mellitus type II	12/13
ECOG performance status
0	14
1	9
2	2
Without/with arterial hypertension	3/22
Without/with coronary artery disease	14/11
Laboratory-chemical values prior to SIRT
Glomerular filtration rate prior to therapy^b
< 90 mL/min/1.73 m²	20
> 90 mL/min/1.73 m²	3
Quick value
Within/below lower limit of normal	20/5
Serum creatinine^b
Within/above or below sex-dependent norm	14/9
Bilirubin total
Within/above upper limit of normal	17/8
Bilirubin direct^a
Within/above upper limit of normal	1/23
Albumin^b
Within/above upper limit of normal	22/1
Aspartate aminotransferase^b
Within/above sex-dependent upper limit of normal	10/13
Alanine aminotransferase^b
Within/above sex-dependent upper limit of normal	12/11
Alkaline phosphatase^b
Within/above sex-dependent upper limit of normal	8/15
Gamma-glutamyl transferase^b
Within/above sex-dependent upper limit of normal	1/22
α-fetoprotein prior to SIRT
< 10 IU/mL	12
> 10 IU/mL	13
α-fetoprotein after SIRT^c
< 10 IU/mL	5
> 10 IU/mL	17

CUP cancer of unknown primary, ECOG Eastern Cooperative Oncology Group

^aOne unknown value

^bTwo unknown values

^cThree unknown values